Tuesday, August 11, 2026

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Samsung Display QD-OLED Monitor Shipments Top 5 Million Units

Samsung Display's QD-OLED monitors surpassed 5 million shipments, marking a significant growth in the premium monitor market.

Korea–U.S. Trade Tensions: Why Seoul Rejects Claims Tying 25% Tariffs to Legislative Delays

Minister Cho Hyun clarifies that Trump's tariff increase is unrelated to Coupang and emphasizes the need for parliamentary consent on trade matters.

Tag: Artiva Biotherapeutics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.